Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Drug Safety|March 1, 2003
Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infectionThierry Lacaze-Masmonteil, Juergen Seidenberg, Ian Mitchell, et al.Pediatrics|May 7, 2014
Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort studyHao Yi, Krista L Lanctôt, Louis Bont, et al.The Journal of Pediatrics|June 26, 2007
Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezingEric A F Simoes, Jessie R Groothuis, Xavier Carbonell-Estrany, et al.Pediatric Pulmonology|October 7, 2017
Caregiver knowledge and skills to safely care for pediatric tracheostomy ventilation at homeReshma Amin, Chris Parshuram, Jeannie Kelso, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2008
Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestationJohn S Sampalis, Joanne Langley, Xavier Carbonell-Estrany, et al.British Journal of Neurosurgery|December 17, 2010
An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspectiveAndrea E Cavanna, Clare M Eddy, Rosalind Mitchell, et al.Hypertension (Dallas, Tex. : 1979)|December 17, 2014
Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysmsRicardo A Peña-Silva, Nohra Chalouhi, Lauren Wegman-Points, et al.Molecular Cancer Therapeutics|April 14, 2007
Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancerDorit Nahari, Ronit Satchi-Fainaro, Ming Chen, et al.Plos One|August 9, 2017
Myofibroblasts are increased in the lung parenchyma in asthmaStacey R Boser, Thais Mauad, Bianca Bergamo de Araújo-Paulino, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2017
Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drugLasantha Gunasekara, Mustafa Al-Saiedy, Francis Green, et al.Pageof 10